The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference
The Oncology Institute (NASDAQ:TOI), a leader in value-based community oncology care, will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference. CEO Dr. Daniel Virnich and CFO Rob Carter will deliver a presentation on October 8, 2025 at 11:00 AM ET.
Investors can access the presentation webcast by registering through the company's Investor Relations website at investors.theoncologyinstitute.com.
Il The Oncology Institute (NASDAQ: TOI), leader nella cura oncologica comunitaria basata sul valore, parteciperà alla Noble Capital Markets Emerging Growth Virtual Equity Conference. Il CEO Dr. Daniel Virnich e il CFO Rob Carter presenteranno l'8 ottobre 2025 alle 11:00 ET.
Gli investitori possono accedere alla webcast della presentazione registrandosi tramite il sito di Relazioni con gli Investitori dell'azienda all'indirizzo investors.theoncologyinstitute.com.
El Instituto de Oncología (NASDAQ: TOI), líder en atención oncológica comunitaria basada en el valor, participará en la Noble Capital Markets Emerging Growth Virtual Equity Conference. El CEO Dr. Daniel Virnich y el CFO Rob Carter ofrecerán una presentación el 8 de octubre de 2025 a las 11:00 a. m. hora del Este.
Los inversionistas pueden acceder a la transmisión de la presentación registrándose a través del sitio de Relaciones con los Inversores de la empresa en investors.theoncologyinstitute.com.
The Oncology Institute(NASDAQ: TOI)는 가치 기반 지역사회 종양학 진료의 선두주자로서 Noble Capital Markets Emerging Growth Virtual Equity Conference에 참여합니다. CEO Dr. Daniel Virnich와 CFO Rob Carter가 2025년 10월 8일 동부 표준시 11:00에 발표합니다.
투자자들은 회사의 Investor Relations 웹사이트 investors.theoncologyinstitute.com에서 등록하여 발표 생중계를 이용할 수 있습니다.
L'Institut d'Oncologie (NASDAQ: TOI), leader des soins oncologiques communautaires axés sur la valeur, participera à la Noble Capital Markets Emerging Growth Virtual Equity Conference. Le PDG Dr. Daniel Virnich et le CFO Rob Carter présenteront le 8 octobre 2025 à 11h00 ET.
Les investisseurs peuvent accéder à la présentation en webcast en s'inscrivant via le site Relations avec les Investisseurs de l'entreprise à l'adresse investors.theoncologyinstitute.com.
Das Oncology Institute (NASDAQ: TOI), führend in wertorientierter gemeinschaftlicher Krebsbehandlung, wird am Noble Capital Markets Emerging Growth Virtual Equity Conference teilnehmen. CEO Dr. Daniel Virnich und CFO Rob Carter werden am 8. Oktober 2025 um 11:00 Uhr Eastern Time eine Präsentation halten.
Investoren können sich über die Website des Investor Relations-Teams des Unternehmens unter investors.theoncologyinstitute.com registrieren, um die Präsentation im Webcast zu verfolgen.
معهد الأورام (الـ Nasdaq: TOI)، الرائد في رعاية الأورام المجتمعية القائمة على القيمة، سيشارك في مؤتمر Noble Capital Markets Emerging Growth Virtual Equity Conference. الرئيس التنفيذي الدكتور دانيال فيرنش والمدير المالي روبرت كارتر سيقدمان عرضاً في 8 أكتوبر 2025 الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة.
يمكن للمستثمرين الوصول إلى العرض عبر الويب من خلال التسجيل عبر موقع علاقات المستثمرين للشركة على investors.theoncologyinstitute.com.
The Oncology Institute (NASDAQ: TOI)，在基于价值的社区肿瘤科护理领域处于领先地位，将参加 Noble Capital Markets Emerging Growth Virtual Equity Conference。CEO Dr. Daniel Virnich 与 CFO Rob Carter 将于 2025年10月8日美东时间11:00 进行演讲。
投资者可通过公司投资者关系网站 investors.theoncologyinstitute.com 注册参加在线广播。
- None.
- None.
CERRITOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference, on October 8, 2025, including a presentation at 11:00am ET.
Interested parties can access a webcast of the presentation by registering at the link listed on the Investor Relations section of the Company’s websites at https://investors.theoncologyinstitute.com/.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
When is TOI presenting at the Noble Capital Markets Conference?
Who will represent TOI at the Noble Capital Markets Conference?
How can investors access TOI's Noble Capital Markets Conference presentation?
What is The Oncology Institute's stock symbol?
